Blog / Archives
The Biotech Bull Market: Just Hold the Course and Let Profits Ride… Update 1
Rayno Life Science: Mid-Day Movers - IBB down 0.9% UP Diagnostics and Tools: Cepheid (CPHD) up 2.55%.Hologic (HOLX) up 3.7%, Response Genetics (RGDX) up 3.2% Biopharmaceuticals: Array (ARRY) up...
Watch For Sell-Off Tomorrow-Caution Urged Update 1 7/19
7/19 11:45a EDT Update -Correction Limited to Techs, Biotechs Surge Tech correction continues with XLK down 1.5% but more money finding its way into biotech "bubblet" with IBB ($195) up...
Life Science Mutual Funds and ETFs: Up 30-46% 2013 YTD
"1,2,3 Click" -Investing in Life Sciences The bull market in biotech is big and broad enough to make everyone look good and one fund or ETF can "deliver alpha" without exhaustive research or stock...
Biotech Stocks Have A Bit of a MO-Off Day: AEGR, PCYC, MDVN, REGN
Biotech Stocks Take A Breather: NASDAQ off 0.3% at 3597 A little profit taking has set in after it seemed that the market would roar all summer. From the action in mid-cap biopharma stocks it looks...
Biotech Funds and ETFS:JNGLX,FBDIX,FBIOX
See This Week's issue of Barron's (JY 15 p 31) for a good summary of the biotech sector. See also our article at bottom of page from Investor Uprising in 2011.We have covered many ETFs and funds...
Bernanke Bounce Carries Biotechs To New Highs
Strong NASDAQ Up 1.35%-IBB Hits 188.82 All Time High A stealth rally that began with futures after the close yesterday was triggered by Bernanke comments interpreted by the market as backtracking on...
Futures Up After Bernanke Speech
Run the Presses-Money That Is Buy Stocks, Bonds, Gold? It could be a knee jerk reaction but investors are bullish after Bernanke says economy still needs help from stimulative money policy. Low...
A Risk Off Day But With Nice Gains in Biotech: ALXN, AMGN, PCYC, VRML
Rayno Life Science Movers 2% or more Alexion (ALXN $97.8) up 2.14% Amgen (AMGN $100.71) up 2.4% Pharmacyclics (PCYC $100.55) up 12% Vermillion (VRML $2.90) up 10.6% After a 4 day S&P rally up...
Life Science Stocks Mixed But New Highs In ABAX, AMRI, QDEL, RGDX
Life Science Stocks Are Mixed-Biopharma Weak But Diagnostics Strong The life science sector traded along with NASDAQ today so as the NAZ sold off (tech stock weakness) biotech followed. The IBB...
Rayno Life Science Portfolios July 1, 2013 Update
Biotechnology Sector (IBB 178) Up Over 30% YTD Many Rayno Focus Stocks Outperformed the Market NASDAQ 3431 , S&P 1615 Biopharmaceutical-Top 5 Stocks- % Up YTD Albany Molecular (AMRI) 140.7...